As­traZeneca's new EVP of in­ter­na­tion­al amid Chi­na in­ves­ti­ga­tion; Janux’s $300M of­fer­ing

Plus, news about Ar­rakis, Eli Lil­ly, Ever­est Med­i­cines, Te­va, Ron­do Ther­a­peu­tics, Tre­vi Ther­a­peu­tics, Fore­see Phar­ma­ceu­ti­cals and Rev­o­lu­tion Med­i­cines:

As­traZeneca taps new leader to run Chi­na …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER